Pituitary SCIE

国际简称：PITUITARY 参考译名：垂体

主要研究方向：医学-内分泌学与代谢非预警期刊审稿周期：约6月

《垂体》(Pituitary)是一本由Springer US出版的以医学-内分泌学与代谢为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

2区中科院分区
Q2 JCR分区
72 年发文量
3.3 IF影响因子
未开放 是否OA
57 H-index
1998 创刊年份
Quarterly 出版周期
English 出版语言

Pituitary is an international publication devoted to basic and clinical aspects of the pituitary gland. It is designed to publish original, high quality research in both basic and pituitary function as well as clinical pituitary disease.

The journal considers:

Biology of Pituitary Tumors

Mechanisms of Pituitary Hormone Secretion

Regulation of Pituitary Function

Prospective Clinical Studies of Pituitary Disease

Critical Basic and Clinical Reviews

Pituitary is directed at basic investigators, physiologists, clinical adult and pediatric endocrinologists, neurosurgeons and reproductive endocrinologists interested in the broad field of the pituitary and its disorders. The Editorial Board has been drawn from international experts in basic and clinical endocrinology. The journal offers a rapid turnaround time for review of manuscripts, and the high standard of the journal is maintained by a selective peer-review process which aims to publish only the highest quality manuscripts. Pituitary will foster the publication of creative scholarship as it pertains to the pituitary and will provide a forum for basic scientists and clinicians to publish their high quality pituitary-related work.

[ 查看全部 ]

投稿咨询加急咨询

投稿热线：400-888-7501

Pituitary期刊信息

ISSN：1386-341X
出版语言：English
是否OA：未开放
E-ISSN：1573-7403
出版地区：UNITED STATES
是否预警：否
出版商：Springer US
出版周期：Quarterly
创刊时间：1998
开源占比：0.2943
Gold OA文章占比：31.73%
OA被引用占比：0.2315...
出版国人文章占比：0.06
出版撤稿占比：0
研究类文章占比：79.17%

Pituitary CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

7.1

1.091

1.209

学科类别	分区	排名	百分位
大类：Medicine 小类：Endocrinology, Diabetes and Metabolism	Q2	66 / 244	73%
大类：Medicine 小类：Endocrinology	Q2	44 / 128	66%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Pituitary中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	2区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	3区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	3区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	3区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	3区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	2区

Pituitary JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：ENDOCRINOLOGY & METABOLISM	SCIE	Q2	77 / 186	58.9%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ENDOCRINOLOGY & METABOLISM	SCIE	Q2	64 / 186	65.86%

Pituitary历年数据统计

影响因子

中科院分区

Pituitary中国学者发文选摘

1、A systematic literature review to evaluate extended dosing intervals in the pharmacological management of acromegaly
Author: Fleseriu, M.; Zhang, Z.; Hanman, K.; Haria, K.; Houchard, A.; Khawaja, S.; Ribeiro-Oliveira, A., Jr.; Gadelha, M.

Journal: PITUITARY. 2023; Vol. 26, Issue 1, pp. 9-41. DOI: 10.1007/s11102-022-01285-1
2、Serum biomarkers of colonic polyps in patients with acromegaly: a meta-analysis and systematic review
Author: Ji, Xiaoyu; Fu, Jiajia; Li, Xiaozhe; Yuan, Kun; Sun, Xuebo; Yao, Qiaoling

Journal: PITUITARY. 2023; Vol. 26, Issue 1, pp. 1-8. DOI: 10.1007/s11102-022-01287-z
3、A procedure in mice to obtain intact pituitary-infundibulum-hypothalamus preparations: a method to evaluate the reconstruction of hypothalamohypophyseal system
Author: Li, Kai; Xiong, Zhiwei; Zhou, Mingfeng; Ou, Yichao; Li, Weizhao; Wu, Guangsen; Che, Mengjie; Gong, Haodong; Wang, Xingqin; Peng, Junjie; Zheng, Xiaoxuan; Li, Jiahui; Feng, Zhanpeng; Peng, Junxiang

Journal: PITUITARY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s11102-023-01299-3
4、AcroVoice: the controversial values in reflecting acromegaly disease activity
Author: Zihao Wang, Bing Xing

Journal: Pituitary, 2019, Vol., , DOI:10.1007/s11102-019-00950-2
5、Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China
Author: Yanyan Wu, Lu Gao, Xiaopeng Guo, Zihao Wang, Wei Lian, Kan Deng, Lin Lu, Bing Xing, Huijuan Zhu

Journal: Pituitary, 2019, Vol., , DOI:10.1007/s11102-019-00939-x
6、A small 3D-printing model of macroadenomas for endoscopic endonasal surgery
Author: Xing Huang, Zhen Liu, Xuan Wang, Xu-dong Li, Kai Cheng, Yan Zhou, Xiao-bing Jiang

Journal: Pituitary, 2018, Vol., , DOI:10.1007/s11102-018-0927-x
7、Transsphenoidal approach for pituitary adenomas in patients with McCune–Albright syndrome
Author: Wanchen Dou, Xiao Di, Renzhi Wang, Huijuan Zhu, Yong Yao, Kan Deng, Ming Feng, Guilin Li, Junji Wei

Journal: Pituitary, 2012, Vol.16, 231-237, DOI:10.1007/s11102-012-0408-6
8、Downregulation of Insulin-like growth factor binding protein 6 is associated with ACTH-secreting pituitary adenoma growth
Author: Yakun Yang, Miaomiao Sheng, Fengming Huang, Dechao Bu, Xiaohai Liu, Yong Yao, Congxin Dai, Bowen Sun, Jindong Zhu, Yonghui Jiao, Zhenqing Wei, Huijuan Zhu, Lin Lu, Yi Zhao, Chengyu Jiang, Renzhi Wang

Journal: Pituitary, 2013, Vol.17, 505-513, DOI:10.1007/s11102-013-0535-8